NO124540B - - Google Patents
Download PDFInfo
- Publication number
- NO124540B NO124540B NO1819/68A NO181968A NO124540B NO 124540 B NO124540 B NO 124540B NO 1819/68 A NO1819/68 A NO 1819/68A NO 181968 A NO181968 A NO 181968A NO 124540 B NO124540 B NO 124540B
- Authority
- NO
- Norway
- Prior art keywords
- pipecoloxylidide
- butyl
- levo
- tartrate
- dextro
- Prior art date
Links
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 69
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 50
- 229940095064 tartrate Drugs 0.000 claims description 25
- 150000003839 salts Chemical class 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 13
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 11
- 238000009835 boiling Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 229960001270 d- tartaric acid Drugs 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 5
- 230000006208 butylation Effects 0.000 claims description 4
- 229960001367 tartaric acid Drugs 0.000 claims description 4
- 239000011975 tartaric acid Substances 0.000 claims description 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 3
- FEWJPZIEWOKRBE-LWMBPPNESA-N levotartaric acid Chemical compound OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 235000002906 tartaric acid Nutrition 0.000 claims description 3
- 238000011081 inoculation Methods 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 28
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- 239000002585 base Substances 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 14
- 239000002244 precipitate Substances 0.000 description 10
- 238000003756 stirring Methods 0.000 description 9
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- 229910021529 ammonia Inorganic materials 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 238000003776 cleavage reaction Methods 0.000 description 6
- 230000007017 scission Effects 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- -1 dextro-2' Chemical class 0.000 description 4
- 239000003589 local anesthetic agent Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000007790 scraping Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 3
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 230000029142 excretion Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 150000003840 hydrochlorides Chemical class 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 210000001557 animal structure Anatomy 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229960002409 mepivacaine Drugs 0.000 description 1
- INWLQCZOYSRPNW-UHFFFAOYSA-N mepivacaine Chemical compound CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C INWLQCZOYSRPNW-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000007738 vacuum evaporation Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63927767A | 1967-05-18 | 1967-05-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO124540B true NO124540B (de) | 1972-05-02 |
Family
ID=24563449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO1819/68A NO124540B (de) | 1967-05-18 | 1968-05-10 |
Country Status (13)
| Country | Link |
|---|---|
| AT (2) | AT286298B (de) |
| BE (1) | BE715188A (de) |
| CH (1) | CH498834A (de) |
| DE (1) | DE1770408C3 (de) |
| DK (1) | DK129234B (de) |
| ES (1) | ES354352A1 (de) |
| FI (1) | FI50333C (de) |
| FR (2) | FR1583872A (de) |
| GB (1) | GB1180712A (de) |
| IL (1) | IL29958A (de) |
| NL (1) | NL6806995A (de) |
| NO (1) | NO124540B (de) |
| SE (1) | SE341404B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU560367B2 (en) * | 1983-08-01 | 1987-04-02 | Astra Lakemedel Aktiebolag | L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same |
| SE451840B (sv) * | 1986-01-03 | 1987-11-02 | Astra Laekemedel Ab | Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning |
| CA2200355C (en) * | 1994-10-25 | 2007-03-06 | Marianne Langston | Crystallisation of levobupivacaine and analogues thereof |
| SE9501808D0 (sv) * | 1995-05-16 | 1995-05-16 | Astra Ab | New process |
| KR100844336B1 (ko) * | 2007-01-16 | 2008-07-07 | 하나제약 주식회사 | 레보부피바카인 및 이의 염산염의 신규한 제조방법 |
| WO2014009964A1 (en) * | 2012-07-11 | 2014-01-16 | Neon Laboratories Limited | Process for enantiomeric enrichment of 2 ', 6 ' - pipecoloxylidide |
| CN105315196A (zh) * | 2015-11-28 | 2016-02-10 | 山东齐都药业有限公司 | 一种高纯度盐酸左布比卡因精制方法 |
| CN109896992A (zh) * | 2017-12-08 | 2019-06-18 | 武汉软件工程职业学院 | 制备离子液体的方法及其应用 |
-
1968
- 1968-05-02 SE SE05905/68A patent/SE341404B/xx unknown
- 1968-05-07 IL IL29958A patent/IL29958A/xx unknown
- 1968-05-10 GB GB22420/68A patent/GB1180712A/en not_active Expired
- 1968-05-10 NO NO1819/68A patent/NO124540B/no unknown
- 1968-05-14 DE DE1770408A patent/DE1770408C3/de not_active Expired
- 1968-05-15 BE BE715188D patent/BE715188A/xx unknown
- 1968-05-16 DK DK226968AA patent/DK129234B/da unknown
- 1968-05-16 ES ES354352A patent/ES354352A1/es not_active Expired
- 1968-05-17 NL NL6806995A patent/NL6806995A/xx unknown
- 1968-05-17 FI FI681394A patent/FI50333C/fi active
- 1968-05-17 CH CH733568A patent/CH498834A/de not_active IP Right Cessation
- 1968-05-17 AT AT1097469A patent/AT286298B/de not_active IP Right Cessation
- 1968-05-17 FR FR1583872D patent/FR1583872A/fr not_active Expired
- 1968-05-17 AT AT475368A patent/AT284843B/de not_active IP Right Cessation
- 1968-08-16 FR FR163282A patent/FR8160M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DK129234C (de) | 1975-02-03 |
| IL29958A0 (en) | 1968-07-25 |
| FR1583872A (de) | 1969-12-05 |
| CH498834A (de) | 1970-11-15 |
| NL6806995A (de) | 1968-11-19 |
| DE1770408A1 (de) | 1971-10-21 |
| FI50333C (fi) | 1976-02-10 |
| BE715188A (de) | 1968-09-30 |
| DE1770408C3 (de) | 1974-11-07 |
| DK129234B (da) | 1974-09-16 |
| DE1770408B2 (de) | 1974-04-11 |
| FI50333B (de) | 1975-10-31 |
| ES354352A1 (es) | 1969-11-01 |
| GB1180712A (en) | 1970-02-11 |
| AT286298B (de) | 1970-12-10 |
| IL29958A (en) | 1971-04-28 |
| AT284843B (de) | 1970-09-25 |
| FR8160M (de) | 1970-08-24 |
| SE341404B (de) | 1971-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO131329B (de) | ||
| NO153082B (no) | Apparat for stapping av en rynket roerformet omhylling | |
| NO171453B (no) | Fremgangsmaate for fremstilling av krystallinsk paroxetin-hydroklorid-hemihydrat | |
| NO124540B (de) | ||
| USRE29588E (en) | Preparation of d-2-amino-1-butanol salts | |
| CH445512A (de) | Verfahren zur Herstellung von neuen Indolderivaten | |
| US2831027A (en) | Isocamphane compounds and processes for preparing the same | |
| NO120686B (de) | ||
| NO166164B (no) | Festeanordning til aa etablere elektrisk forbindelse med en engangs hudelektrode. | |
| Pyman | LXXXIV.—The constitution of the anhydro-bases derived from tetrahydroberberine alkyl hydroxides | |
| NO141161B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive morfinanderivater | |
| Ingersoll et al. | Solubility Relationships among Optically Isomeric Salts. IV. Salts of 6, 6'-Dinitrodiphenic Acid, a New Type of Resolving Agent | |
| US2906757A (en) | Their preparation | |
| NO126914B (de) | ||
| NO140378B (no) | Fremgangsmaate for fremstilling av 1-(3,5-dihydroksyfenyl)-1-hydroksy-2-(1-methyl-2-(4-hydroksyfenyl)-etyl)-aminoetan | |
| DE1802297B2 (de) | Isopropylaminderivate und Verfahren zu ihrer Herstellung | |
| PT91145B (pt) | Processo para a sintese de amino-acidos opticamente activos | |
| US3629289A (en) | Chromanamines | |
| US3085110A (en) | Resolution of n-d-and n-1-sec-butylcyclo-hexylamine by methyl hydrogen di-benzoyl-d tartrate | |
| NO150553B (no) | Oppblaasbar baat | |
| US3534142A (en) | Methods of treating tapeworm infections with naphthamidines | |
| WO2011051957A2 (en) | A process for the preparation of donepezil hydrochloride | |
| CH460773A (de) | Verfahren zur Herstellung von substituierten 3-(3-Hydroxyphenyl)-1-phenacyl-piperidinen | |
| US2724710A (en) | 4-pyridazinecarboxylic acid and salts thereof with bases | |
| WO2009084030A2 (en) | Improved process for the preparation of (1-benzyl-4-(5,6,- dimethoxyind anone-2-yl)methylpiperidine) hydrochloride-form iii |